SCHEMBL3420037

SCHEMBL3420037

O=c1[nH]c2nccn2c2[nH]ncc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
ADORA2A P29274 1/20 0.34
SLC6A4 P31645 1/20 0.34
ADRA1A P35348 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
PARP1 P09874 2/20 0.34
ALDH1A1 P00352 2/20 0.33
PDE2A O00408 1/20 0.33
PDE6D O43924 1/20 0.33
PDE8A O60658 1/20 0.33
PDE5A O76074 1/20 0.33
PDE9A O76083 1/20 0.33
PDE8B O95263 1/20 0.33
PDE6A P16499 1/20 0.33
PDE6G P18545 1/20 0.33
PDE4A P27815 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14060874 0.70 PDE2A (0.36) PARP1PDE2APDE6DPDE8APDE5A
SCHEMBL232090 0.69 PNP (0.37) PARP1PDE2APDE6DPDE8APDE5A
SCHEMBL12638629 0.69 PARP1 (0.41) PARP1PDE2APDE6DPDE8APDE5A
SCHEMBL3420036 0.68 PDE3B (0.36) PDE2APDE6DPDE8APDE5APDE9A
SCHEMBL24932075 0.65 TP53 (0.41) PARP1ALDH1A1PDE2APDE6DPDE8A
SCHEMBL24931693 0.64 PDE3B (0.42) SMN1; SMN2LMNAALDH1A1PDE3BPDE3A
SCHEMBL24222070 0.64 PDE2A (0.33) XDHPDE2APDE6DPDE8APDE5A
SCHEMBL2450155 0.62 PDE3B (0.37) PDE2APDE6DPDE8APDE5APDE9A
SCHEMBL232091 0.62 PDE4A (0.47) ADORA2ABLMALDH1A1PDE2APDE6D
SCHEMBL7700737 0.61 PDE3B (0.39) XDHPDE2APDE6DPDE8APDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010065149-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2010-06-10 WO claimed
EP-2367429-B1 ORGANIC COMPOUNDS INTRA CELLULAR THERAPIES INC (US) 2017-06-07 EP disclosed
CN-102231953-A Organic compounds INTRA CELLULAR THERAPIES INC 2011-11-02 CN disclosed
WO-2010065149-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2010-06-10 WO disclosed